Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000919574-16-014070
Filing Date
2016-07-12
Accepted
2016-07-12 17:04:10
Documents
1
Period of Report
2016-07-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT p7203273.html 4  
1 OWNERSHIP DOCUMENT p7203273.xml 4 20077
  Complete submission text file 0000919574-16-014070.txt   21429
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Issuer) CIK: 0001327467 (see all company filings)

EIN.: 202680869 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CAXTON ALTERNATIVE MANAGEMENT LP 1330 SIXTH AVENUE, 20TH FLOOR NEW YORK NY 10019
Business Address
Morenstein Scott D (Reporting) CIK: 0001576113 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36179 | Film No.: 161764450